Literature DB >> 27136400

Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?

Rhonda Voskuhl1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27136400     DOI： 10.1001/jamaneurol.2016.0934

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  3 in total

1.  Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

Authors:  Noriko Itoh; Roy Kim; Mavis Peng; Emma DiFilippo; Hadley Johnsonbaugh; Allan MacKenzie-Graham; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

2.  Dramatic rebounds of MS during pregnancy following fingolimod withdrawal.

Authors:  Giovanni Novi; Angelo Ghezzi; Matteo Pizzorno; Caterina Lapucci; Fabio Bandini; Pietro Annovazzi; Giovanni L Mancardi; Antonio Uccelli
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-27

3.  Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.

Authors:  Victor Gomez-Mayordomo; Paloma Montero-Escribano; Jordi A Matías-Guiu; Nuria González-García; Jesús Porta-Etessam; Jorge Matías-Guiu
Journal:  J Med Virol       Date:  2020-07-15       Impact factor: 20.693
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.